Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on FormS-3 of our report dated July 30, 2018, relating to the consolidated financial statements of KalVista Pharmaceuticals, Inc. appearing in the Annual Report onForm 10-K of KalVista Pharmaceuticals, Inc. for the year ended April 30, 2018, and to the reference to us under the heading “Experts” in the Prospectus, which is part of this Registration Statement.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
December 14, 2018
